We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Dosage for Cardiac Dual-Source CT Can Be Significantly Lowered

By MedImaging International staff writers
Posted on 13 Aug 2008
Print article
A new study reveals that by using dual-source computed tomography (DSCT), the effective dosage for a heart examination can be significantly lowered, in comparison to conventional CT. The study also demonstrated that stenoses could be diagnosed with similar high accuracy as with invasive X-ray angiography.

At the University Hospital Zürich (Switzerland), 120 patients with suspected coronary heart disease were scanned with the world's first CT scanner with two X-ray tubes, a Somatom Definition system, developed by Siemens Healthcare (Erlangen, Germany). The Siemens application, Adaptive Cardio Sequence with a step-and-shoot mode, was also used for the first time with a dual-source CT. The results of the study were published in the June 2008, issue of the journal Heart.

Angiography is a diagnostic procedure used to determine coronary arterial occlusion. Typically, this examination is conducted using angiography devices in the catheter laboratory and CT images. However, with CT, the question of the radiation dosage plays a huge role. Researchers at the University Hospital now want to see whether the dose used during CT angiography can be reduced.

The research team used Adaptive Cardio Sequence, which was recently developed by Siemens for all Somatom Definition Scanners. The application is based on the step-and-shoot method, in which the next respective diastole is calculated, and only this phase of the cardiac cycle is used to obtain image data. The combination of Adaptive Cardio Sequence and the DSCT's maximum time resolution of 83 ms facilitate this technique in a particularly effective manner and permits a further significant reduction in dosage.

"The results show that CT coronary angiography with a dual-source CT in step-and-shoot mode produces images of excellent diagnostic quality in patients with stable heart rates up to 70 bpm. The dosage reduction achieved in comparison to previous CT angiography is also remarkable. In our study, we required an effective dose of 2.5 mSv on average with a deviation of plus or minus 0.8 mSv. In the literature, a normal average effective dose for heart scans of between 9 mSv and 21 mSv is reported,” said Dr. Hatem Alkadhi, specialist in radiology at the Institute for Diagnostic Radiology, University Hospital Zürich.

The Adaptive Cardio Sequence supplements the step-and-shoot method with intelligent algorithms, which monitor the heart frequency of patients, and if necessary, respond to arrhythmia, such as extra systoles (i.e., additional heart beats). In this case, the recording phase is automatically postponed to avoid image errors due to the sudden movement. Moreover, the recording window can be widened a little more if required so that, using the Adaptive Cardio Sequence, the robustness of the CT scan can be increased significantly overall.

"For Siemens, the safety of the patients has always been the primary focus of the developments in CT. At the same time, we consider our highest obligation to be to give doctors the best diagnostic image quality and to support them in making their workflow as efficient as possible. With this outlook and constant further development, Siemens has positioned itself as a market leader in CT technology,” said Dr. Sami Atiya, CEO, Computed Tomography, Siemens Healthcare. "Innovations for dose reduction, in conjunction with improved diagnostic image quality, are therefore of the utmost importance to us. This is why we have also further developed our Adaptive Cardio Sequence, now for the dual-source CT. The study from Zurich confirms to us that the combination of step-and-shoot and dual-source computed tomography does significantly reduce the dosage required during heart scans.”

Related Links:
University Hospital Zurich
Siemens Healthcare


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Laptop Ultrasound Scanner
PL-3018
New
Digital Radiography Generator
meX+20BT lite
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers

Print article

Channels

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The Cinematic Reality app enables interaction with realistic renderings of human anatomy (Photo courtesy of Siemens)

AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning

Siemens Healthineers (Erlangen, Germany) has launched an app designed for Apple Vision Pro that allows users including surgeons, medical students, or patients to view immersive, interactive holograms of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.